OSTX 株価推移チャート
OSTX 株価予測
OS Therapies Inc
$1.63
-7.64%
$-0.13
終値： Apr 28, 16:00:00 GMT-4
$1.67
2.45%
$0.04
プレマーケット： Apr 29, 08:10:46 GMT-4
戻る
OS Therapies Inc (OSTX) 株価予測
主要データ
前終値
$1.76
始値
$1.8
当日レンジ
$1.62 - $1.85
52週レンジ
$1.15 - $2.57
取引高
1.3M
平均取引高
575.4K
配当利回り
--
1株当たり利益(TTM)
-0.96
時価総額
$70.2M
OSTXとは何ですか？
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2024-08-01. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.
